美国,Advanced BioScience Laboratories,
Advanced BioScience Laboratories, Inc (ABL) 是马里兰州的生物医学研究公司，专责为生物医学团体提供资源开发和评估各种疫苗，治疗和诊断传染源。ABL是一个高度专业的合同研究组织(CRO ),具有与政府，商业和其他团体合作的丰富经验。ABL致力于预防艾滋病毒和传染病的研究。ABL可以帮助各个领域的产品开发，包括：基础研究，疫苗或产品设计，具有免疫调控的动物模型，为第一阶段和第二阶段的临床试验生产cGMP生物制品以及许多其他服务。
ABL有着数以百计的出版物和在艾滋病毒和传染病领域几十年的研究经验。
ABL有着悠久的历史，为客户提供免疫调控服务( ELISA方法，抗原表位的映射，免疫印迹，淋巴细胞的分离，流式细胞仪， elispot等) ，细胞库，并扩增和QC病毒(HIV, SIV, Vaccinia, CMV, HTLV, and FIV)和杂交瘤。
ABL还可以提供一系列广泛的病毒学检测方法的研究使用，如通过NASBA进行RNA的病毒载量测试，抗病毒和病毒中和试验,RIPA，抗原捕获，检测的RT和其它许多相关服务。
ABL还针对HIV，SIV和病毒学研究提供各种特殊产品，包括抗体，抗原，高免疫血清，病毒原液和抗原捕获试剂盒。




Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, partnering with our clients to advance their vaccine and therapeutic development programs. Our unique combination of preclinical and clinical services provide the tools to address the scientific challenges encountered during any stage of product development. For preclinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. Once a clinical candidate is identified, ABL's in-house cGMP suites are designed for single-use technologies accommodating a wide range of products, including mammalian- and microbial-based protein therapeutics as well as viral vectors and vaccines.